Social Anxiety Disorder 上市

The reviews of social anxiety disorder drugs provided data for articles entitled Reporting Bias in Clinical Trials Investigating the Efficacy of Second-Generation Antidepressants in the Treatment of Anxiety Disorders, Spin in RCTs of anxiety medication with a positive primary outcome: a comparison of concerns expressed by the US FDA and in the published literature, Influence of baseline severity on antidepressant efficacy for anxiety disorders: meta-analysis and meta-regression, and Bias in the reporting of harms in clinical trials of second-generation antidepressants for depression and anxiety: A meta-analysis.

Descriptions

行动

作品在此集合

对列表中单件排序    
以如下方式察看搜索结果:
List of items in this collection
  Title Date Uploaded Visibility
  2018-11-13 上市
Creator:
United States. Food and Drug Administration.
Depositor:
bess@curationexperts.com
Edit Access:
Groups: admin
Users: bess@curationexperts.com
  2018-11-13 上市
Creator:
United States. Food and Drug Administration.
Depositor:
bess@curationexperts.com
Edit Access:
Groups: admin
Users: bess@curationexperts.com
  2018-11-13 上市
Creator:
United States. Food and Drug Administration.
Depositor:
bess@curationexperts.com
Edit Access:
Groups: admin
Users: bess@curationexperts.com
  2018-11-13 上市
Creator:
United States. Food and Drug Administration.
Depositor:
bess@curationexperts.com
Edit Access:
Groups: admin
Users: bess@curationexperts.com
  2018-11-12 上市
Creator:
United States. Food and Drug Administration.
Depositor:
bess@curationexperts.com
Edit Access:
Groups: admin
Users: bess@curationexperts.com